Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Chemokine signaling is important for hair development.

Mice genetically modified to produce more Del1 protein had faster hair regrowth.

Celiac disease patients often have psoriasis, dermatitis herpetiformis, and alopecia areata, but rarely vitiligo.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.

Atopic dermatitis increases the risk of some autoimmune diseases.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Common gene patterns may cause skin autoimmune diseases.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Type I interferons play a key role in the development of various skin diseases.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Some children may develop hair loss after having COVID-19.